Skip to main content
Lytix Biopharma AS (OSL:LYTIX)
Norway flag Norway · Delayed Price · Currency is NOK
10.20
0.00 (0.00%)
At close: Dec 5, 2025

Lytix Biopharma AS Revenue

Lytix Biopharma AS had revenue of 377.00K NOK in the twelve months ending September 30, 2025, down -96.50% year-over-year. In the year 2024, Lytix Biopharma AS had annual revenue of 11.13M with 178.98% growth.

Revenue (ttm)
377.00K
Revenue Growth
-96.50%
P/S Ratio
1,846.88
Revenue / Employee
47.13K
Employees
8
Market Cap
696.27M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202411.13M7.14M178.98%
Dec 31, 20233.99M-7.04M-63.82%
Dec 31, 202211.03M-8.28M-42.87%
Dec 31, 202119.31M15.23M373.91%
Dec 31, 20204.07M-2.27M-35.73%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 662.18M
Nordhealth AS 590.33M
Photocure ASA 537.59M
ArcticZymes Technologies ASA 109.99M
Omda AS 476.29M
Vistin Pharma ASA 455.25M
Gentian Diagnostics ASA 172.52M
Nykode Therapeutics AS 73.37M
Revenue Rankings